Status:

TERMINATED

Indole-3-Carbinol Effects on Estrogen Metabolism

Lead Sponsor:

University of Wisconsin, Madison

Conditions:

Obesity

Eligibility:

FEMALE

30-50 years

Phase:

PHASE2

Brief Summary

This study will test a dietary supplement, indole-3-carbinol, for improving the estrogen profile in women across a range of body mass index.

Eligibility Criteria

Inclusion

  • woman aged from 30 - 50 years
  • regular menstrual cycle

Exclusion

  • taking hormone replacement or hormonal contraception
  • thyroid disorder
  • uncontrolled asthma
  • BMI under 18.5
  • allergy to cruciferous vegetables

Key Trial Info

Start Date :

September 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2014

Estimated Enrollment :

38 Patients enrolled

Trial Details

Trial ID

NCT00988845

Start Date

September 1 2009

End Date

January 1 2014

Last Update

December 13 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Wisconsin

Madison, Wisconsin, United States, 53792